Atlas Genetics raised €32M in a Series D+ round in Jan 2017. The company is based in Bristol, UK. Investors in the round: BB Biotech Ventures, Global Life Science Ventures, Johnson & Johnson Innovation and 4 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €32M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
